Skip to main content
. 2013 Aug 6;4(10):974–978. doi: 10.1021/ml4002437

Table 1. In Vitro Growth Inhibitory Activities against Various Cancer Cell Lines.

cancer type cell line characteristic 9n (μM) 9p (μM) gefitinib (μM)
epidemal A431 EGFRWT,overexpression 2.2 0.9 4.0
NSCLC H1975 EGFRL858R/T790M 4.9 3.61 10.48
NSCLC A549 EGFRWT,κ-Ras mutation >10 >10 >10
colon SW620 EGFR negative 25.4 6.2 28.20
malignant myeloid K562 EGFR negative >10 >10 >10